Characterization of TRBP-containing complexes
含TRBP复合物的表征
基本信息
- 批准号:7146839
- 负责人:
- 金额:$ 28.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-08-01 至 2010-07-31
- 项目状态:已结题
- 来源:
- 关键词:RNA interferencecell linedouble stranded RNAenzyme complexgel mobility shift assaygene deletion mutationgenetic regulationgenetic translationmicroRNAsmonoclonal antibodyoncoproteinsposttranscriptional RNA processingprotein localizationprotein protein interactionprotein purificationprotein structure functionrecombinant proteinsribonuclease IIIribonucleoproteinssmall interfering RNAsynthetic nucleic acid
项目摘要
DESCRIPTION (provided by applicant): The microRNA-group of genes of C. elegans is required to control the timing of larval development and neuronal patterning. A predominant number of these genes are conserved in mammals and recent experiments demonstrated a role for them in modulation of hematopoietic differentiation and cancer. Our biochemical characterization of microRNA pathway revealed the association of the RNase III enzyme Dicer with the oncogenic protein TRBP. Dicer is the enzyme responsible for the generation of mature microRNA and processing of exogenous double-stranded RNA to short interfering RNAs (siRNAs). Biochemical analysis of TRBP-containing complexes not only confirmed the association of TRBP and Dicer but also uncovered the presence of Argonaute 2, the catalytic engine of RNA-induced silencing complex as a stable component of Dicer/TRBP complex. We hypothesize that these three proteins form the core of a complex responsible for processing and execution of RNAi response. We also uncovered evidence indicating that the 60S ribosome subunit associates with TRBP to form a complex involved in mediating microRNA-directed translational repression. Aim 1 will define the function of Dicer/TRBP complex in the genesis of siRNA/miRNA and begin to examine the role of individual proteins and their domain structure in the regulation of siRNA/miRNA processing activity. Aim 2 describes the detailed functional analysis of the association of Dicer/TRBP complex with the effector complex containing the Ago2 subunit and delineates the role of individual proteins in the functioning of the posttranscriptional gene silencing. Aim 3 extends the work to the analysis of the large TRBP- containing complex, which is associated with the 60S ribosome subunit and the human Armitage protein involved in translational repression.
描述(申请人提供):线虫的microRNA基因组需要控制幼虫发育和神经元模式的时间。这些基因中的大多数在哺乳动物中是保守的,最近的实验表明它们在调节造血分化和癌症方面发挥了作用。我们对microRNA途径的生化特征表明,RNaseIII酶Dester与致癌蛋白TRBP有关。DICER是一种酶,负责产生成熟的microRNA,并将外源双链RNA加工成短干扰RNA(SiRNAs)。对含有TRBP的复合体进行生化分析,不仅证实了TRBP与DICER的结合,而且揭示了作为DICER/TRBP复合体的稳定组分的RNA诱导沉默复合体的催化引擎ArgAerte 2的存在。我们假设这三种蛋白质形成了负责处理和执行RNAi反应的复合体的核心。我们还发现了证据表明,60S核糖体亚单位与TRBP结合,形成一种复合体,参与介导microRNA导向的翻译抑制。目的1将确定DICER/TRBP复合体在siRNA/miRNA发生中的功能,并开始研究单个蛋白质及其结构域在调节siRNA/miRNA加工活性中的作用。目的2详细分析DICER/TRBP复合体与含有Ago2亚单位的效应复合体的结合,并阐明单个蛋白质在转录后基因沉默功能中的作用。目的3将工作扩展到含有TRBP的大型复合体的分析,该复合体与60S核糖体亚基和参与翻译抑制的人类Armitage蛋白有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KAZUKO NISHIKURA其他文献
KAZUKO NISHIKURA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KAZUKO NISHIKURA', 18)}}的其他基金
Stress Response Functions of ADAR1 Regulated by MAP Kinases
MAP 激酶调控 ADAR1 的应激反应功能
- 批准号:
10330572 - 财政年份:2019
- 资助金额:
$ 28.08万 - 项目类别:
Stress Response Functions of ADAR1 Regulated by MAP Kinases
MAP 激酶调控 ADAR1 的应激反应功能
- 批准号:
10093094 - 财政年份:2019
- 资助金额:
$ 28.08万 - 项目类别:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
EB 病毒 microRNA 控制乳腺癌转移
- 批准号:
8625434 - 财政年份:2014
- 资助金额:
$ 28.08万 - 项目类别:
Control of Breast Cancer Metastasis by Epstein-Barr Virus microRNA
EB 病毒 microRNA 控制乳腺癌转移
- 批准号:
9187428 - 财政年份:2014
- 资助金额:
$ 28.08万 - 项目类别:
Control of Cardiogenesis by microRNA Editing
通过 microRNA 编辑控制心脏发生
- 批准号:
7934485 - 财政年份:2009
- 资助金额:
$ 28.08万 - 项目类别:
Control of Cardiogenesis by microRNA Editing
通过 microRNA 编辑控制心脏发生
- 批准号:
7810127 - 财政年份:2009
- 资助金额:
$ 28.08万 - 项目类别:
Functions of ADARI RNA Editase in Erythropoiesis
ADARI RNA 编辑酶在红细胞生成中的功能
- 批准号:
6746917 - 财政年份:2002
- 资助金额:
$ 28.08万 - 项目类别:
Functions of ADARI RNA Editase in Erythropoiesis
ADARI RNA 编辑酶在红细胞生成中的功能
- 批准号:
6465404 - 财政年份:2002
- 资助金额:
$ 28.08万 - 项目类别:
Functions of ADARI RNA Editase in Erythropoiesis
ADARI RNA 编辑酶在红细胞生成中的功能
- 批准号:
6833858 - 财政年份:2002
- 资助金额:
$ 28.08万 - 项目类别:
Functions of ADARI RNA Editase in Erythropoiesis
ADARI RNA 编辑酶在红细胞生成中的功能
- 批准号:
6912766 - 财政年份:2002
- 资助金额:
$ 28.08万 - 项目类别:
相似海外基金
Establishment of a Mouse NK Cell Line for Analyzing Tumor Infiltration Processes and Developing a Preclinical Model for Cancer Immunotherapy.
建立小鼠 NK 细胞系,用于分析肿瘤浸润过程并开发癌症免疫治疗的临床前模型。
- 批准号:
23K06731 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Proof of usefulness of PDX derived cell line
PDX 衍生细胞系的有用性证明
- 批准号:
23K06616 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A novel producer cell line for more efficient manufacturing of viral vector systems
用于更有效地制造病毒载体系统的新型生产细胞系
- 批准号:
10597799 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Genestorian: a web application to document and trace genetic modifications in model organism and cell line collections.
Genestorian:一个网络应用程序,用于记录和追踪模型生物和细胞系集合中的遗传修饰。
- 批准号:
EP/Y024591/1 - 财政年份:2023
- 资助金额:
$ 28.08万 - 项目类别:
Fellowship
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10672364 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Developing a stable cell line expressing recombinant sclerostin
开发表达重组硬化素的稳定细胞系
- 批准号:
10385037 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Development of Natural Killer (NK) Cell Line-Derived Extracellular Vesicles as a New Treatment for Cancer
开发自然杀伤 (NK) 细胞系衍生的细胞外囊泡作为癌症的新治疗方法
- 批准号:
10383462 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
A cell culture management platform to improve biomedical reproducibility by combining cell line tracking, low-cost genetic analysis, and riskassessment
细胞培养管理平台,通过结合细胞系追踪、低成本遗传分析和风险评估来提高生物医学重现性
- 批准号:
10483063 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
AI-Aided Tool for Day Zero Selection of High Performing Cells for Biopharma Cell Line Development
用于生物制药细胞系开发的高性能细胞零日选择的人工智能辅助工具
- 批准号:
10546865 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Modulating expression of candidate genes to improve lentiviral vector production in stable cell line
调节候选基因的表达以提高稳定细胞系中慢病毒载体的产量
- 批准号:
2752732 - 财政年份:2022
- 资助金额:
$ 28.08万 - 项目类别:
Studentship